Long intergenic non-protein coding RNA 1413 (LINC01413)

Long intergenic non-protein coding RNA 1413 (LINC01413) is a member of the long intergenic non-coding RNA (lincRNA) family. LINC01413 is autonomously transcribed, longer than 200 nucleotides, and does not overlap coding genes[1][5][3]. LincRNAs such as LINC01413 are known for regulatory roles in chromatin remodeling, genome architecture, RNA stabilization, and transcription regulation; some influence enhancer activity and gene expression in a tissue-specific manner[3][7]. Although LINC01413 itself is not a canonical therapeutic target like a receptor or enzyme, the broader lincRNA class—including LINC01413—is extensively studied for its roles in cancer biology and fine-tuning gene expression, though disease associations and mechanisms are still being established[3][7]. There are no drugs currently targeting LINC01413 directly, and it is not established as a biomarker or therapeutic drug target in clinical practice[1][5].

Other names

LINC01413